Menu
Consulting to BD&L
Is your current process not working as expected?
Do you need a second opinion on a valuation or Term Sheet?
Is you drug candidate licensable at this stage?
Are these presentations good enough?
What is my candidate actually worth?
Am I structuring this transaction properly?
How will my Board react to my proposed deal?
These and related questions are on the minds of C-level executives who are running or overseeing any in- or out-licensing process.
We get it…and we can help.
We can review all aspects of your process (presentations, data rooms, tracking metrics, and expectations) and provide specific recommendations for improving your process.
We audit existing in- or out-licensing processes by reviewing the overall strategy, presentations, conferences, personnel…everything that can make the difference between a transformative transaction or another year answering questions from the Board.
